Intra-Cellular Therapies ... (ITCI)
128.57
-0.03 (-0.02%)
At close: Feb 20, 2025, 3:59 PM
128.96
0.30%
After-hours: Feb 20, 2025, 05:38 PM EST
Intra-Cellular Therapies Inc. Analyst Ratings
Total Analysts
13
Consensus Rating
Hold
Price Target
100
Upside
-22.22
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Date |
Sumant Kulkarni (0)
| Canaccord Genuity | Hold | Downgrades | 119 132 | Jan 31, 2025 |
Brian Abrahams (0)
| RBC Capital | Hold | Downgrades | 108 132 | Jan 22, 2025 |
David Amsellem (0.59)
| Piper Sandler | Hold | Downgrades | 107 132 | Jan 14, 2025 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options Data
- Instant access to live options data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.